| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |